RIVAS MARIO (Chief Executive Officer) reported 1 transaction at TRANSPHORM, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/4/2022ACC: 0001209191-22-001277
DirectorOfficer· Chief Executive Officer
Since Feb 2020
-11.85K
Net shares
Net seller
$94.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
11.85K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.85K
Price / share
$8.00
Trade value
$94.78K
% of position
8.9%
1/1/2022
133.62K→121.77K
Total
Net shares
−11.85K
Net value
-$94.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2022 | F · Tax Withholding | −11.85K | $8.00 | $94.78K | 8.9% | 133.62K | 121.77K |
| Total | −11.85K | -$94.78K | ||||||
Derivative Transactions0
No derivative transactions reported